This study aims to calibrate the Multiple Sclerosis Functional Composite (MSFC) for home implementation in a phase 2 trial of lisinopril in multiple sclerosis. In this initial stage, participants are required to travel to the study site one day a week for three weeks to complete the MSFC. They are also required to complete the MSFC at home once weekly for three weeks using remote sensing technology and video conferencing.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
20
The MSFC is a diagnostic test that measures multiple sclerosis symptoms. It includes a timed walk test, 9-hole peg test, and paced auditory serial addition test. The MSFC is administered in-person at the study site.
The mMSFC is a diagnostic test that measures multiple sclerosis symptoms from. It includes a timed walk test, 9-hole peg test, and paced auditory serial addition test. All aspects of this exam are completed from a participant's home using remote sensing technology and video conferencing.
Icahn School of Medicine at Mount Sinai
New York, New York, United States
RECRUITINGSafety of mMSFC Tally
Safety of remote video administration of the mMSFC will be calculated at the end of the study by calculating and comparing the instances of balance-related safety issues.
Time frame: Week 6
MSFC Score Comparison
mMSFC scores will be compared to MSFC scores for proof of calibration.
Time frame: Week 6
Mobile Timed Walk Test Value Comparison
Mobile timed walk times will be compared to 25-foot timed walk test times for proof of calibration.
Time frame: Week 6
Mobile 9-hole Peg Test Time Comparison
Mobile 9HPT time will be compared to 9 HPT time for proof of calibration.
Time frame: Week 6
Mobile Paced Auditory Serial Addition Test Score Comparison
Mobile PASAT3 scores will be compared to PASAT3 scores for proof of calibration.
Time frame: Week 6
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.